News

The Board of Directors of the FSP have made recommendations for a revision of the current bylaws which will be reviewed and voted on at the next FSP Business Meeting on Saturday February 14, 2026.

Get to know your fellow FSP members!

The FSP Nominating Committee, chaired by Marilyn Bui, MD, PhD, recommends the slate of candidates for Executive Committee and At-Large Member Board positions for the 2026-2028 term.

Get to know your fellow FSP members!

Get to know your fellow FSP members!

Get to know your fellow FSP members!

Get to know your fellow FSP members!

AbbVie (NYSE: ABBV) announced on May 14, 2025 that EMRELIS™ (telisotuzumab vedotin-tllv) has been granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with locally advanced or metastatic, non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein overexpression (OE) who have received a prior systemic therapy.

Get to know your fellow FSP members!

Get to know your fellow FSP members!